Guidance for Hospitals on Containing Spread of COVID-19 CDC Evaluating and Testing Persons Under Investigation (PUI) for COVID-19 Clinical Guidelines Show All Medication Questions & Answers Media Gallery Tables ReferencesRecommended Drugs COVID-19 vaccine, adjuvanted-Novavax Medscape Now! Hot Topic...
Herein, we provide operational COVID-19 vaccine guidance for patients participating in oncology clinical trials. In our perspective, continued quality oncological care requires that patients with cancer, including those involved in trials, be prioritized for COVID-19 vaccination, which should not affect...
Clinical Editors: Megan Dodson, PA-C, Spencer Blackman, MD, Will Kimbrough, MD One Medical supports vaccination as an important measure to reduce the spread and harm from COVID-19, and we want you to have the most updated vaccine information. Here are our answers to some of your most co...
Coronavirus Disease 2019 (COVID-19): A Clinical Guide provides healthcare professionals at all levels with up-to-date knowledge about the clinical, epidemiological, genomic, virological, and radiologic features of COVID-19. Consolidating multiple systematic reviews and meta-analyses into a single vo...
Considering the high morbidity and mortality from COVID-19 in patients with cancer, the benefits of vaccination are likely to far outweigh the risks of vaccine-related adverse events. Herein, we provide operational COVID-19 vaccine guidance for patients participating in oncology clinical trials. In...
However, the data of phase I and II clinical trials has shown that the vaccines are safe. The concentration of vaccine-induced neutralizing antibody is slightly lower than observed in people aged between 18 and 59, but the positive conversion rate of the neutralizing an...
1 Shared decision-making regarding timing of surgery after SARS-CoV-2 infection between patient and multidisciplinary clinical teams must consider: severity of the initial infection; ongoing symptoms of COVID- 19; comorbid and functional status, b...
7 Vaccination several weeks before surgery will reduce risk to patients and might lessen the risk of nosocomial SARS-CoV-2 infection of other patients and staff. National vaccine committees should consider whether such patients can be prioritised for vaccination. ...
BEIJING, Sept. 6 (Xinhua) -- Two Chinese inactivated vaccines, including a trivalent one and a monovalent one against Omicron variants, have received approval for clinical research in Chile, the vaccine developer Sinovac has announced. The trivalent vaccine targets the Delta and Omicron variants alo...
This is the first COVID-19 mRNA vaccine to be approved for clinical trials in China. A staff member displays samples of the COVID-19 inactivated vaccine at Sinovac Biotech Ltd., in Beijing, capital of China, March 16, 2020. (Xinhua/Zhang Yuwei) ...